![Ann Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Lee
Directeur Technique/Scientifique/R&D chez
PRIME MEDICINE, INC.
Fortune : 439 249 $ au 31/05/2026
Profil
Ann L.
Lee currently serves as Director at the American Institute of Chemical Engineers, Alliance for Regenerative Medicine, and JW Therapeutics (Shanghai) Co., Ltd. Dr. Lee is an Independent Director at Coya Therapeutics, Inc. since 2021.
Dr. Lee is a Member of the Washington State Academy of Sciences and the National Academy of Engineering.
Since 2021, Dr. Lee has been Chief Technical Officer at Prime Medicine, Inc. Former roles include Director at JW (Cayman) Therapeutics Co. Ltd., SVP, Head of Cell Therapy Development & Operations at Bristol Myers Squibb Co. from 2019 to 2021, EVP-Cell Therapy Development & Operations at Celgene Corp.
from 2018 to 2019, SVP & Global Head-Pharma Technical Development at Genentech, Inc. from 2009 to 2017, VP-Chemical Technology & Engineering at Merck Research Laboratories Massachusetts LLC, VP-Process Engineering & Technical Operations at Merck & Co., Inc. from 1989 to 2005, SVP & Head-Global Technical Development at Roche Corp.
from 2010 to 2017, and Executive Vice President-Technical Operations at Juno Therapeutics, Inc. from 2017 to 2018.
Education includes undergraduate degree from Cornell University and graduate and doctorate degrees from Yale University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRIME MEDICINE, INC. 0,06% | 31/03/2026 | 100 000 ( 0,06% ) | 355 000 $ | 31/05/2026 |
| 01/05/2026 | 17 479 ( 0,07% ) | 84 249 $ | 31/05/2026 |
Postes actifs de Ann Lee
| Sociétés | Poste | Début |
|---|---|---|
| PRIME MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 01/10/2021 |
| COYA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/06/2021 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Membre du Conseil | - |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Directeur/Membre du Conseil | - |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
American Institute of Chemical Engineers
 American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Directeur/Membre du Conseil | - |
Washington State Academy of Sc
 Washington State Academy of Sc Miscellaneous Commercial ServicesCommercial Services The Washington State Academy of Sciences (WSAS) is an independent, nonpartisan, nonprofit scientific advisory organization established by the state legislature in 2005 to provide objective scientific and technical information to state policymakers, agencies, and the governor’s office. The private company is located in the US. WSAS mobilizes over 400 volunteer scientists from academia, industry, and government across diverse disciplines to conduct evidence-based assessments on issues such as clean energy, salmon recovery, transportation resilience, environmental contaminants, public health, and emerging technologies. It produces peer-reviewed reports, white papers, and convenes experts through workshops, symposia, and topical affinity groups to foster multidisciplinary collaboration. The academy supports science education and the next generation of scientists through programs like the Washington Junior Academy of Sciences and a planned science policy fellowship program. WSAS is guided by a board of directors and staffed by experts in science policy and communications, emphasizing expertise, objectivity, collaboration, inclusivity, and timely communication to promote science-informed decision-making. It engages with legislators and the public through newsletters, events, and legislative workshops, aiming to enhance the impact of scientific research on public policy, and is committed to diversity, equity, and inclusion. | Corporate Officer/Principal | - |
Anciens postes connus de Ann Lee
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/07/2021 |
| CELGENE | Corporate Officer/Principal | 01/11/2019 |
| ░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Ann Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
88
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
American Institute of Chemical Engineers
American Institute of Chemical Engineers Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization for chemical engineers | Commercial Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Roche Corp. | |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Washington State Academy of Sc
Washington State Academy of Sc Miscellaneous Commercial ServicesCommercial Services The Washington State Academy of Sciences (WSAS) is an independent, nonpartisan, nonprofit scientific advisory organization established by the state legislature in 2005 to provide objective scientific and technical information to state policymakers, agencies, and the governor’s office. The private company is located in the US. WSAS mobilizes over 400 volunteer scientists from academia, industry, and government across diverse disciplines to conduct evidence-based assessments on issues such as clean energy, salmon recovery, transportation resilience, environmental contaminants, public health, and emerging technologies. It produces peer-reviewed reports, white papers, and convenes experts through workshops, symposia, and topical affinity groups to foster multidisciplinary collaboration. The academy supports science education and the next generation of scientists through programs like the Washington Junior Academy of Sciences and a planned science policy fellowship program. WSAS is guided by a board of directors and staffed by experts in science policy and communications, emphasizing expertise, objectivity, collaboration, inclusivity, and timely communication to promote science-informed decision-making. It engages with legislators and the public through newsletters, events, and legislative workshops, aiming to enhance the impact of scientific research on public policy, and is committed to diversity, equity, and inclusion. | Commercial Services |
